ASS1 and colorectal carcinoma: High levels of argininosuccinic acid are expected in colorectal cancer since almost all CRC subtypes present argininosuccinate synthase [39], an adaptation of the cancer cells to synthesize arginine starting from citrulline, with targeting arginine metabolism being an avenue explored for its potential in CRC treatment [40].